Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024

The fluid that feeds tumor cells

by Anne Trafton,Massachusetts Institute of TechnologyPancreatic cancer cells (nuclei in blue) growing as a sphere encased in membranes (red). By growing cancer cells in the lab, researchers can

Updated on: April 01,2024

The fluid that feeds tumor cells

by Anne Trafton,Massachusetts Institute of TechnologyPancreatic cancer cells (nuclei in blue) growing as a sphere encased in membranes (red). By growing cancer cells in the lab, researchers can

Updated on:April 01,2024

Study finds that diabetes may hasten breast cancer tumor growth and stiffness

byVanderbilt UniversityHyperglycemia increases tumor growth through promoting cell proliferation. (A) Weekly average tumor volume measurements for nondiabetic (Ctrl), diabetic (STZ), and diabeti

Updated on: January 23,2024

Study finds that diabetes may hasten breast cancer tumor growth and stiffness

byVanderbilt UniversityHyperglycemia increases tumor growth through promoting cell proliferation. (A) Weekly average tumor volume measurements for nondiabetic (Ctrl), diabetic (STZ), and diabeti

Updated on:January 23,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on: January 29,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on:January 29,2024

The importance of nutrition and physical activity for cancer patients and their caregivers

by Drexel UniversityCredit: Unsplash/CC0 Public DomainIt is well known that a healthy diet and physical activity are beneficial to cancer survivorship. But support for the physical and dietary he

Updated on: February 20,2024

The importance of nutrition and physical activity for cancer patients and their caregivers

by Drexel UniversityCredit: Unsplash/CC0 Public DomainIt is well known that a healthy diet and physical activity are beneficial to cancer survivorship. But support for the physical and dietary he

Updated on:February 20,2024

Study uncovers genetic cancer risks in 550 patients

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainCurrent screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian

Updated on: August 01,2024

Study uncovers genetic cancer risks in 550 patients

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainCurrent screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian

Updated on:August 01,2024

Mass spectrometry can monitor treatment response in multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 inBlood Cancer Journa

Updated on: February 23,2024

Mass spectrometry can monitor treatment response in multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 inBlood Cancer Journa

Updated on:February 23,2024

'Fingerprint database' could help scientists to identify new cancer culprits

by University of CambridgeCredit: CC0 Public DomainScientists in Cambridge and London have developed a catalogue of DNA mutation 'fingerprints' that could help doctors pinpoint the enviro

Updated on: April 10,2024

'Fingerprint database' could help scientists to identify new cancer culprits

by University of CambridgeCredit: CC0 Public DomainScientists in Cambridge and London have developed a catalogue of DNA mutation 'fingerprints' that could help doctors pinpoint the enviro

Updated on:April 10,2024

Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort

by Public Library of ScienceThe consumption of foods with higher scores on the British Food Standards Agency nutrient profiling system (FSAm-NPS), reflecting a lower nutritional quality, is assoc

Updated on: May 23,2024

Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort

by Public Library of ScienceThe consumption of foods with higher scores on the British Food Standards Agency nutrient profiling system (FSAm-NPS), reflecting a lower nutritional quality, is assoc

Updated on:May 23,2024

New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

by University of MalagaNew therapy proposed to treat "axillary web syndrome" in women who have had a mastectomy. Credit: University of MalagaAxillary web syndrome, also known as lymphatic th

Updated on: January 15,2024

New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

by University of MalagaNew therapy proposed to treat "axillary web syndrome" in women who have had a mastectomy. Credit: University of MalagaAxillary web syndrome, also known as lymphatic th

Updated on:January 15,2024

US regulators approve 2nd gene therapy for blood cancer

by Linda A. JohnsonIn this May 2016 file photo provided by Kite Pharma, cell therapy specialists at the company's manufacturing facility in El Segundo, Calif., prepare blood cells from a patient t

Updated on: March 12,2024

US regulators approve 2nd gene therapy for blood cancer

by Linda A. JohnsonIn this May 2016 file photo provided by Kite Pharma, cell therapy specialists at the company's manufacturing facility in El Segundo, Calif., prepare blood cells from a patient t

Updated on:March 12,2024

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h

Updated on: March 30,2024

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h

Updated on:March 30,2024